Atossa Therapeutics, Inc.
- Last sale
- Nov 12, 2026 · -3.94%
- Market cap
- $19.46M
- 9.98M shares
- Filings
- 643
Q3 2016−95.6% FY15 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026−41.9% FY25 yoy
- $19.46M
- —
- —
- 0.9×
- -153.06%
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2015 | 2015-12-31 | $1,758 | reported | |
| FY 2014 | 2014-12-31 | $40,138 revised | reported | |
| FY 2013 | 2013-12-31 | $632,558 | reported | |
| FY 2012 | 2012-12-31 | $481,842 | reported | |
| FY 2011 | 2011-12-31 | $1,500 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2024 | — | $0.00 | $0.00 | — | 129.17M sh | +3.1% | — |
| FY2023 | — | $1.48M | $1.48M | — | 125.30M sh | −1.0% | — |
| FY2022 | — | $0.00 | $0.00 | — | 126.62M sh | ±0.0% | — |
Pharmaceutical preparations
Atossa Therapeutics, Inc. is the 388th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
TXMDTherapeuticsMD, Inc.$3.0M71.6%18.8%$20.9MEDSAEdesa Biotech, Inc.———$20.1MKYNBKyntra Bio, Inc.$6.4M78.3%2,848.6%$19.6MCOCPCocrystal Pharma, Inc.———$19.6M
ATOSAtossa Therapeutics, Inc. (this company)———$19.5M
AYTUAytu Biopharma, Inc$57.6M13.3%24.8%$19.4MBIOEBio Essence Corp$1.9M485.8%47.2%$19.0MXTLBXTL Biopharmaceuticals LtdFiscal 2024 figures———$18.1MLPCNLipocine Inc.$2.0M82.3%487.1%$17.9MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Atossa Therapeutics, Inc. · CIK 1488039 · Engraved from SEC EDGAR